Which single laboratory or imaging finding best distinguishes acute interstitial oedematous pancreatitis from acute necrotizing pancreatitis?

Explanation

## Morphological Classification of Acute Pancreatitis: Edematous vs. Necrotizing ### Revised Atlanta Classification (2012) The morphological distinction between edematous and necrotizing acute pancreatitis is the most important radiological discriminator and is best identified on **contrast-enhanced CT (CECT)**. | Feature | Interstitial Edematous | Acute Necrotizing | |---------|------------------------|-----------| | **Pathology** | Pancreatic oedema without necrosis | Pancreatic and/or peripancreatic necrosis | | **CT appearance** | Homogeneous enhancement of pancreas | Heterogeneous enhancement; areas of non-enhancement | | **Prognosis** | Mortality 1–3% | Mortality 10–30% | | **Organ failure** | Rare | Common (30–50%) | | **Infected necrosis** | N/A | 10–30% of necrotizing cases | | **ICU admission** | Rarely needed | Often required | ### Why Contrast Enhancement Is the Best Discriminator **Key Point:** On dynamic contrast-enhanced CT, the pancreatic parenchyma shows homogeneous enhancement in edematous pancreatitis but heterogeneous or absent enhancement in necrotizing pancreatitis. This is the gold standard for morphological classification. **High-Yield:** - **Edematous pancreatitis**: The pancreatic parenchyma enhances uniformly with intravenous contrast because blood flow is preserved and the tissue remains viable. - **Necrotizing pancreatitis**: Areas of necrosis do NOT enhance (appear dark/hypodense) because there is loss of microvascular perfusion and tissue death. The presence of non-enhancing pancreatic parenchyma ≥ 30% of the gland volume defines necrotizing pancreatitis. **Clinical Pearl:** CECT is performed at 72 hours or later in the course of acute pancreatitis because early imaging (< 48 hours) may underestimate necrosis. The degree of necrosis correlates with morbidity and mortality and guides management intensity. ### Why Other Features Are Not Discriminatory - **Serum amylase > 1000 U/L**: Elevated in both edematous and necrotizing pancreatitis; does not distinguish morphology. - **Peripancreatic fluid**: Can be present in both types; not specific for necrosis. Peripancreatic fluid collections are common in edematous pancreatitis and do not indicate necrotizing disease. - **Coagulopathy (elevated PT, thrombocytopenia)**: Indicates severe systemic inflammation and organ failure, which is more common in necrotizing pancreatitis but can occur in severe edematous pancreatitis. Not a direct discriminator of morphology. ```mermaid flowchart TD A[Acute Pancreatitis diagnosed<br/>Amylase/Lipase elevated]:::outcome --> B[Perform CECT at 72 hours]:::action B --> C{Pancreatic parenchyma<br/>enhancement pattern?}:::decision C -->|Homogeneous enhancement| D[Interstitial Edematous<br/>Pancreatitis]:::outcome C -->|Heterogeneous or<br/>non-enhancement ≥30%| E[Acute Necrotizing<br/>Pancreatitis]:::outcome D --> F[Mortality 1-3%<br/>Supportive care]:::action E --> G[Mortality 10-30%<br/>ICU, close monitoring]:::urgent ``` [cite:Harrison 21e Ch 367]